OpenAI's CEO of AGI deployment, Fidji Simo, is stepping down from her full-time role and becoming a part-time adviser after taking extended medical leave for a chronic neuroimmune condition. "Three months ago, I had to go on medical leave after a severe exacerbation of a chronic illness I've lived with for seven years," Simo wrote in a post Thursday on X. "During that time, it became clear that the road to recovery would be much longer and more complex than I had anticipated -- and that I needed to focus on it fully." Wired reports: Simo joined OpenAI's board of directors in March 2024. The following year, CEO Sam Altman hired her to take on the product and business organizations so he could focus on research and the company's data center buildout. Previously, Simo was the CEO of Instacart and head of the Facebook app at Meta.

Shortly before starting at OpenAI, Simo experienced a significant health relapse. She was diagnosed with postural tachycardia syndrome, or POTS, in 2019. "For my entire time here, I've postponed medical tests and new therapies to stay completely focused on the job and not miss a single day of work," she told OpenAI staff in a memo back in April, announcing her temporary departure. "It's now clear that I've pushed a little too far and I really need to try new interventions to stabilize my health."

News of Simo's medical leave came amid a larger executive shakeup that saw Brad Lightcap, OpenAI's former COO, transition to a role overseeing special projects. OpenAI president and cofounder Greg Brockman took over OpenAI's product strategy. In the months since Simo stepped back from OpenAI, the company further reorganized its product teams, positioning Thibault Sottiaux as head of the company's core products, including ChatGPT.

Read more of this story at Slashdot.